Related references
Note: Only part of the references are listed.Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: a meta-analysis of observational studies
Junli Park et al.
CARCINOGENESIS (2022)
Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
Pavlina Spiliopoulou et al.
MOLECULAR CANCER THERAPEUTICS (2022)
The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
Yu Wang et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Insights Into the Role of Epigenetic Factors Determining the Estrogen Response in Estrogen-Positive Ovarian Cancer and Prospects of Combining Epi-Drugs With Endocrine Therapy
Sadia Sarwar et al.
FRONTIERS IN GENETICS (2022)
The Origin of Ovarian Cancer Species and Precancerous Landscape
Ie-Ming Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Progesterone induces apoptosis by activation of caspase-8 and calcitriol via activation of caspase-9 pathways in ovarian and endometrial cancer cells in vitro
Latoya McGlorthan et al.
APOPTOSIS (2021)
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins
Minh Tung Phung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers
Adrian Ramirez-de-Arellano et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Usha Menon et al.
LANCET (2021)
Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
Sandra Munoz-Galvan et al.
CANCERS (2021)
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Torgny Karlsson et al.
CANCER RESEARCH (2021)
Effects of high progesterone in in-vitro fertilization cycle on DNA methylation and gene expression of adhesion molecules on endometrium during implantation window
Yujing Xiong et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2020)
Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes
Daniela Matei et al.
CANCER RESEARCH (2020)
Estrogen-induced epigenetic silencing ofFTH1andTFRCgenes reduces liver cancer cell growth and survival
Jibran Sualeh Muhammad et al.
EPIGENETICS (2020)
Estradiol-Induced Epigenetically Mediated Mechanisms and Regulation of Gene Expression
Tamas Kovacs et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Progesterone decreases ovarian cancer cells migration and invasion
Maira A. Lima et al.
STEROIDS (2020)
Genome-wide methylation profiles in monozygotic twins with discordance for ovarian carcinoma
Ozge Sukruoglu Erdogan et al.
ONCOLOGY LETTERS (2020)
Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue
Angiolo Gadducci et al.
ANTICANCER RESEARCH (2020)
Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer
Enrique Pedernera et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Breast cancer risk of hormonal contraception: Counselling considering new evidence
Lino Del Pup et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk
Annelie Johansson et al.
CLINICAL EPIGENETICS (2019)
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
Zachary L. Watson et al.
CLINICAL EPIGENETICS (2019)
Ovulation: Parallels With Inflammatory Processes
Diane M. Duffy et al.
ENDOCRINE REVIEWS (2019)
Epigenetics in ovarian cancer
Yanina Natanzon et al.
SEMINARS IN CANCER BIOLOGY (2018)
Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis
Edward Curry et al.
CANCER RESEARCH (2018)
Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction
Allison A. Gockley et al.
CANCER TREATMENT REVIEWS (2018)
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics
Jaime Prat et al.
HUMAN PATHOLOGY (2018)
Screening for Ovarian Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Jillian T. Henderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence
R. Troisi et al.
JOURNAL OF INTERNAL MEDICINE (2018)
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
Dan Liu et al.
NATURE COMMUNICATIONS (2018)
Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers
Kara A. Michels et al.
JAMA ONCOLOGY (2018)
Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions
Thomas R. Pisanic et al.
CLINICAL CANCER RESEARCH (2018)
Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer
James M. Flanagan et al.
CLINICAL CANCER RESEARCH (2017)
Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells
Yu-Wei Chang et al.
PLOS ONE (2017)
Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells
Na-Yiyuan Wu et al.
CELL REPORTS (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer
David Klinkebiel et al.
MOLECULAR CANCER RESEARCH (2016)
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
Thomas E. Bartlett et al.
NATURE COMMUNICATIONS (2016)
Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators
Georgette Moyle-Heyrman et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
Joan L. Walker et al.
CANCER (2015)
Combined oral contraceptive synergistically activates mineralocorticoid receptor through histone code modifications
Adedoyin Igunnu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Breastfeeding and Ovarian Cancer Risk: a Systematic Review and Meta-analysis of 40 Epidemiological Studies
Da-Peng Li et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review)
Ourania Koukoura et al.
MOLECULAR MEDICINE REPORTS (2014)
Early Preinvasive Lesions in Ovarian Cancer
Gautier Chene et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
Russell Vang et al.
HISTOPATHOLOGY (2013)
Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer
T. Pal et al.
BRITISH JOURNAL OF CANCER (2012)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Jaime Prat
VIRCHOWS ARCHIV (2012)
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition
K. K. Tsilidis et al.
BRITISH JOURNAL OF CANCER (2011)
SIRT1 Is Essential for Oncogenic Signaling by Estrogen/Estrogen Receptor α in Breast Cancer
Selvakumar Elangovan et al.
CANCER RESEARCH (2011)
Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
Saundra S. Buys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Reversibility of pre-malignant estrogen-induced epigenetic changes
Kristy R. Kutanzi et al.
CELL CYCLE (2010)
Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass Clues to Serous Tumor Origin?
Michael H. Roh et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Increased Ovarian Cancer Risk Associated With Menopausal Estrogen Therapy Is Reduced by Adding a Progestin
Celeste Leigh Pearce et al.
CANCER (2009)
Combined oral contraceptive use and epithelial ovarian cancer risk - Time-related effects
Galina Lurie et al.
EPIDEMIOLOGY (2008)
The cell of origin of ovarian epithelial tumours
Louis Dubeau
LANCET ONCOLOGY (2008)
Gonadotropins and ovarian cancer
Jung-Hye Choi et al.
ENDOCRINE REVIEWS (2007)
Loss of ovarian function and the risk of ovarian cancer
BC Vanderhyden
CELL AND TISSUE RESEARCH (2005)
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
G Gifford et al.
CLINICAL CANCER RESEARCH (2004)
BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis
JMJ Piek et al.
GYNECOLOGIC ONCOLOGY (2003)
Share Paper
